DLA Piper has advised Arize AI. Goodwin has advised Dynatrace. Dynatrace, Inc. has entered into a definitive agreement to acquire Arize AI, a leading AI observability...
Dynatrace to Acquire Arize AI in $915 Million Cash and Stock Deal
Accelerant Enters Into $4 Billion Take-Private Acquisition by Thoma Bravo
Paul Hastings, Sidley Austin, and Maples Group have advised Accelerant. Houlihan Lokey and Conyers Dill & Pearman have advised the Special Committee of Accelerant. Goodwin Procter,...
ARCHIMED Acquires Esperion Therapeutics in $1.1 Billion Transaction
Sidley Austin and Moelis & Company have advised ARCHIMED. Goodwin Procter and Centerview Partners have advised Esperion Therapeutics. Akin Gump has advised Pharmakon Advisors. ARCHIMED, a...
Gilead to Acquire Tubulis in $5 Billion Oncology-Focused Transaction
Covington has advised Gilead Sciences, Inc. CMS and Goodwin Procter have advised Tubulis GmbH. Gilead Sciences, Inc. has entered into a definitive agreement to acquire Tubulis...
Novartis Acquires Pikavation Therapeutics and PI3K? Inhibitor Portfolio from Synnovation for Up to $3 Billion
Goodwin Procter and Mintz have advised Synnovation Therapeutics on the transaction. Novartis has entered into a definitive agreement to acquire Pikavation Therapeutics, Inc., a wholly-owned subsidiary...
Enavate Sciences Invests in Braveheart Bio’s $185 Million Series A Financing
Wilmer Cutler Pickering Hale and Dorr has advised Enavate Sciences. Goodwin Procter has advised Braveheart Bio. Enavate Sciences, a platform of Patient Square Capital, has made...
Merck’s $3.9 Billion Acquisition of SpringWorks Therapeutics
Sullivan & Cromwell advised Merck KGaA, Darmstadt, Germany, while Goodwin Procter advised SpringWorks Therapeutics on the transaction. Skadden advised Centerview Partners and Goldman Sachs & Co....
Novo Holdings’ Investment in Biocomposites
On the deal, Linklaters and Kirkland & Ellis advised Novo Holdings; Goodwin advised TA Associates. Novo Holdings, a holding and investment company responsible for managing the...
1X Technologies’ $100 Million Series B Funding Round
Goodwin advised 1X Technologies on the funding round. 1X Technologies announced the closing of its $100 million Series B financing round that included participation from EQT...
Merck’s $680 Million Acquisition of Harpoon Therapeutics
Evercore Group L.L.C. acted as financial advisor to Merck in this transaction and Covington & Burling LLP acted as its legal advisor. Centerview Partners LLC acted...
HI-Bio’s $95 Million Series B Financing Round
Goodwin advised Human Immunology Biosciences (HI-Bio) on the round. Human Immunology Biosciences (HI-Bio™), a clinical-stage biotechnology company developing targeted therapies for patients with severe immune-mediated diseases (IMDs),...
Miro’s Acquisition of Freehand
Goodwin advised Miro in its acquisition of Freehand. Miro has acquired the visual collaboration platform, Freehand, from InVision. The deal includes the technology and brand assets, customer...